Blood biomarkers for post-stroke cognitive impairment: A systematic review and meta-analysis
Authors:
- 28 February 2024
- journal article
- review article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (8) , 107632
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Association between serum cystatin C level and post‐stroke cognitive impairment in patients with acute mild ischemic strokeBrain and Behavior, 2022
- Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer DiseaseJAMA Neurology, 2021
- Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-studyJournal of Neurology, 2019
- Biological and imaging predictors of cognitive impairment after stroke: a systematic reviewJournal of Neurology, 2018
- Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive ImpairmentNeuroMolecular Medicine, 2018
- Complement in the pathogenesis of Alzheimer’s diseaseSeminars in Immunopathology, 2017
- Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cellsAmino Acids, 2015
- Analysis of Risk Factors for Vascular Cognitive Impairment in Patients with Cerebral InfarctionCell Biochemistry and Biophysics, 2014
- Early biomarkers for post-stroke cognitive impairmentJournal of Neurology, 2012
- Platelet phospholipase A2 activity in patients with Alzheimer’s disease, vascular dementia and ischemic strokeJournal of Neural Transmission, 2007